Response to Letter to the Editor from Zandee and Links: "Metastatic Differentiated Thyroid Cancer Survival Is Unaffected by Mode of Preparation for 131I Administration"
J Endocr Soc. 2023 Jan 25;7(3):bvad005.
doi: 10.1210/jendso/bvad005.
eCollection 2023 Jan 6.
1 MedStar Clinical Research Center, MedStar Health Research Institute (MHRI), Hyattsville, MD 20782-2031, USA.
2 Section of Endocrinology, MedStar Washington Hospital Center, Washington, DC 20010, USA.
3 Department of Internal Medicine, MedStar Washington Hospital Center, Washington, DC 20010, USA.
4 Department of Internal Medicine, Sinai Hospital of Baltimore, Research Volunteer, Baltimore, MD 21215, USA.
5 Department of Biostatistics, MedStar Health Research Institute (MHRI), Hyattsville, MD 20782-2031, USA.
6 Thyroid Tumors and Functional Thyroid Disorders Section, National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases (NIH/NIDDK), Bethesda, MD 20892, USA.
7 Nuclear Medicine Research, MedStar Washington Hospital Center, Washington, DC 20010, USA.
8 Division of Endocrinology, Department of Medicine, Georgetown University, Washington, DC 20057, USA.